LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 39 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $37,809,000 | +15.6% | 37,786,000 | +16.3% | 0.04% | +8.1% |
Q3 2021 | $32,717,000 | -10.0% | 32,500,000 | -11.0% | 0.04% | -9.8% |
Q2 2021 | $36,347,000 | -10.6% | 36,500,000 | -6.4% | 0.04% | -16.3% |
Q1 2021 | $40,659,000 | +137.7% | 39,000,000 | +116.3% | 0.05% | +122.7% |
Q4 2020 | $17,102,000 | -10.1% | 18,031,000 | -13.8% | 0.02% | -18.5% |
Q3 2020 | $19,030,000 | +11.4% | 20,928,000 | +6.0% | 0.03% | +12.5% |
Q4 2019 | $17,090,000 | +20.3% | 19,745,000 | +16.1% | 0.02% | +4.3% |
Q3 2019 | $14,211,000 | +64.1% | 17,000,000 | +70.0% | 0.02% | +64.3% |
Q2 2019 | $8,658,000 | – | 10,000,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |